Home  >  News
Eppen_epTIPS_Jun2026
you can get e-magazine links on WhatsApp. Click here
News
  QubeHealth-Pay closes Series-A at Rs. 416 crore valuation as investors, bet on healthcare as fintech’s next vertical,   June 11, 2026
  Alembic Pharma receives US FDA tentative approval for larotrectinib capsules,   June 11, 2026
  AstraZeneca Pharma India gets CDSCO nod for trastuzumab deruxtecan in combination with pertuzumab for breast cancer,   June 11, 2026
  Remidio receives grant from Gates Foundation to advance retinal imaging-based maternal health screening,   June 11, 2026
  India’s pharmaceutical sector reflects commitment to affordable healthcare: Piyush Goyal,   June 11, 2026
  Union minister Piyush Goyal invites global pharma companies to partner India's growth story,   June 11, 2026
  Akums receives European CEP approval for cefpodoxime proxetil,   June 10, 2026
  Alembic Pharma to acquire 45% stake in Canadian Venture,   June 09, 2026
  Aurobindo Pharma receives final US FDA approval for tofacitinib tablets,   June 09, 2026
  Maiva Pharma inaugurates new state-of-the-art sterile injectable manufacturing facility at Shoolagiri, India,   June 09, 2026
  Haleon firms up to invest Rs. 2,000 crore for its maiden manufacturing unit in India,   June 08, 2026
  Paras Healthcare files DRHP with SEBI,   June 08, 2026
  Alembic Pharma receives US FDA final approval for haloperidol tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg & 20 mg,   June 05, 2026
  Lupin receives US FDA approval for Ranluspec injection,   June 05, 2026
  Wanbury net profit grows 7.2% in Q4 FY26,   June 04, 2026
  Lupin and Natco receive US FDA approval for breast cancer drug eribulin mesylate injection,   June 03, 2026
  Yoginii Partners with Panacea Biotec to introduce infant nutrition products on its platform along with mother, baby-care range,   June 03, 2026
  Aragen to manufacture Renaissance Pharma’s mAb as part of ongoing strategic collaboration,   June 02, 2026
  Lupin receives US FDA approval for sodium sulfate, magnesium sulphate and potassium chloride tablets,   May 30, 2026
  US FDA grants priority review status to Zydus Therapeutics’ NDA for saroglitazar to treat primary biliary cholangitis,   May 29, 2026

  • Results Found: 13300
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 665
 Back
 
Propak_Asia_2026
APME-2026.gif
echemi_logo26
PPPE_2026
cphi_korea2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram